METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION

摘要

FIELD: medicine.;SUBSTANCE: after primary virus remission, Ronkoleukine is introduced in dosage 500 mg with water 200 ml after supper within common interferon therapy, thus taking two courses 5-10 times every second day or 2 times a week. After the third introduction of Ronkoleukine, Likopide is additionally introduced in daily dosage 10 mg once a day within 10 days. Interval between courses is 2 months. If necessary courses are repeated.;EFFECT: prevented disease recurrence and eliminated immunodeficiency manifestation.;2 ex